International Journal of Antimicrobial Agents
Издатель: Elsevier · ISSN 0924-8579 · 80 статей
- Triple carbapenemase-producing Klebsiella pneumoniae ST6668 resistant to novel β-lactam/β-lactamase inhibitor combinations and cefiderocol, Northern Italy, 2025
- Development of antibiotic-associated diarrhoea in sepsis patients is associated with dysbiosis at baseline: Data from the PROGRESS controlled trial
- Comment on strain-dependent variability in pharmacodynamic interactions for phageantibiotic combinations in Pseudomonas aeruginosa
- Comment on “Cefiderocol susceptibility rates in carbapenem-resistant Gram-negative bacteria in a comparative, multicentre surveillance study in China”
- In reply to comment on “Risk factors and serum concentration thresholds associated with tigecycline-induced hepatotoxicity in critically ill patients”
- A novel blaTMB allele encoding a functional carbapenemase associated with a gamma-mobile-trio island
- Comment on “Burden and global distribution of antimicrobial resistance in non-bloodstream infections among adults with cirrhosis: A systematic review and proportional meta-analysis”
- Comment on ‘Cefiderocol susceptibility rates in carbapenem-resistant Gram-negative bacteria in a comparative, multicenter surveillance study in China’
- Doxycycline-containing combination therapy for multidrug-resistant Gram-negative ventilator-associated pneumonia: A prospective observational study
- Identification of a novel SHV beta-lactamase with a tetrapeptide duplication in the omega loop and a resistance profile resembling SHV-16
- Comment on ‘Cefiderocol susceptibility rates in carbapenem-resistant Gram-negative bacteria in a comparative, multicentre surveillance study in China’
- In reply to the letter to editor regarding: “Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa”
- Corrigendum to “Eliminating the tigecycline resistance RND efflux pump gene cluster tmexCD-toprJ in bacteria using CRISPR/Cas9” [International Journal of Antimicrobial Agents 65 (2025) 107390]
- Comment on “Antimicrobial suppressive therapy in prosthetic valve endocarditis rejected from surgery despite indication”
- Comment on “Ceftazidime/avibactam and ceftolozane/tazobactam for severe paediatric infections: A systematic review, metaanalysis, and evidence map”
- Mortality Risk Over Time in Patients with Carbapenem-Resistant Gram-Negative Bloodstream Infections: Implications for Recruitment and Timing of Primary Endpoints in Clinical Trials
- Clinical failure in bloodstream infections extends beyond antimicrobial therapy: Factors associated with individual outcomes in a multicenter prospective cohort study
- Diversity and host association of cfr-carrying plasmids of multidrug-resistant microorganisms from the Netherlands
- In reply to the Letter to Editor regarding “Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy”
- Pharmacokinetics of aztreonam-avibactam during concomitant extracorporeal membrane oxygenation and continuous renal replacement therapy
- Comment on “Development of the Susceptibility–Spectrum Discrepancy Index (S2DI): A novel metric for antimicrobial stewardship in hospitalised patients”
- Comment on “Integrated prediction of ceftriaxone resistance in major Salmonella serotypes using MALDI-TOF MS data with balanced datasets and machine learning”
- Iron deficiency and the fungal protein Dde1 contribute to azole susceptibility in Saccharomyces cerevisiae and Candida glabrata
- Prevalence of new and repurposed drug resistance and associated genetic variants among rifampicin-resistant Mycobacterium tuberculosis in Shenzhen, China: a population-based study
- Conflicts of Interest and Broad-Spectrum First-Line Antibiotic Recommendations in Community-Acquired Pneumonia Guidelines: A Meta-epidemiological Study Using the WHO AWaRe Classification
- Preventive Carbapenem Stewardship and Clinical Outcomes in a Low-Resistance Setting: A Multicenter Quasi-Experimental Study
- The pitfalls of HIV-1 DNA resistance genotyping: What it can and cannot tell us
- Antibacterial dose optimisation in patients with febrile neutropenia: Are we targeting the right patients and the right endpoints?
- Remodelling the host immune microenvironment in carbapenem-resistant Klebsiella pneumoniae: An evidence-graded framework for host-directed intervention
- AI strategies to combat antimicrobial resistance